Quin Technology
Quin creates Virtual Care 2.0 for diabetes, providing digital therapy for self-management with high success rates.
Quin creates Virtual Care 2.0 for diabetes, providing digital therapy for self-management with high success rates.
Quin Technology is a pioneering company in the realm of direct-to-consumer Virtual Care 2.0 for diabetes. It provides digital therapy for self-management with high success rates, surpassing analog healthcare models. Founded in 2014, Quin has garnered significant attention for its innovative approach to managing diabetes 24/7, without relying on human healthcare providers. The company's emphasis on individual needs has resulted in a groundbreaking digital therapy for managing type 1 diabetes. The app consistently ranks among the top #1-3 most downloaded diabetes apps in the UK and Ireland, offering tailored self-management. Reports by Quin users indicate a 96% improvement in overall health and well-being. Furthermore, Quin recently secured a £972.00K Convertible Note investment on 02 February 2021, signifying confidence in its potential for growth and impact in the Health Care industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Convertible Note | £972.00K | - | 02 Feb 2021 | |
| Grant | £97.16K | - | 01 Jul 2020 | |
| Seed Round | £645.00K | - | 04 May 2020 | |
| Equity Crowdfunding | £730.00K | - | 31 Mar 2020 | |
| Grant | £323.00K | - | 30 Nov 2018 |
No recent news or press coverage available for Quin Technology.
We care about your data, and we'd love to use cookies make your experience better.